> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Drug Experiential Learning Site Visits for FY 2025
- URL: https://www.fdaweb.com/drug-experiential-learning-site-visits-for-fy-2025/
- Published: 2024-08-08T12:00:00.000Z
- Updated: 2026-09-14T14:37:46.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5157536

*Federal Register* notice: FDA is announcing its fiscal year 2025 CDER Office of Pharmaceutical Quality (OPQ) Experiential Learning Site Visit Program. Beginning 10/1, drug companies are invited to submit a site visit proposal to CDER’s OPQ. The program is intended to provide first-hand learning opportunities that will provide OPQ staff with a better understanding of the pharmaceutical industry and its operations, as well as the challenges that may impact a drug’s developmental program and commercial life cycle. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2024-08-08/pdf/2024-17640.pdf?ref=fdaweb.com).